Clinigen Group is the global expert in providing access to medicines throughout the life cycle of a treatment, from clinical trials to licensing and commercial supply. Working alongside pharmaceutical firms, biotech companies and healthcare professionals, Clinigen’s mission is to deliver the right medicine to the right patient at the right time. Shaun Chilton joined the firm in 2012 as COO, and during his first year saw Clinigen through its IPO. He then became CEO in 2016. Last year, Chilton oversaw the company’s successful acquisition of Quantum Pharma – the largest healthcare M&A deal in the UK in 2017 – which opened Clinigen up to further opportunities for growth in the coming years.